145 related articles for article (PubMed ID: 23440398)
21. Distinct molecular signatures of mild extrinsic and intrinsic atopic dermatitis.
Martel BC; Litman T; Hald A; Norsgaard H; Lovato P; Dyring-Andersen B; Skov L; Thestrup-Pedersen K; Skov S; Skak K; Poulsen LK
Exp Dermatol; 2016 Jun; 25(6):453-9. PubMed ID: 26841714
[TBL] [Abstract][Full Text] [Related]
22. Prolactin level is significantly elevated in lesional skin of patients with psoriasis.
El-Khateeb EA; Zuel-Fakkar NM; Eid SM; Abdul-Wahab SE
Int J Dermatol; 2011 Jun; 50(6):693-6. PubMed ID: 21595663
[TBL] [Abstract][Full Text] [Related]
23. Production of interleukin-2 by mononuclear cells in vitro in patients with atopic dermatitis and psoriasis. Comparison with serum interleukin-2 receptor levels.
Kapp A; Neuner P; Krutmann J; Luger TA; Schöpf E
Acta Derm Venereol; 1991; 71(5):403-6. PubMed ID: 1684468
[TBL] [Abstract][Full Text] [Related]
24. Activation of the HMGB1‑TLR4‑NF‑κB pathway may occur in patients with atopic eczema.
Wang Y; Weng H; Song JF; Deng YH; Li S; Liu HB
Mol Med Rep; 2017 Sep; 16(3):2714-2720. PubMed ID: 28713916
[TBL] [Abstract][Full Text] [Related]
25. Relationship between the Degrees of Itch and Serum Lipocalin-2 Levels in Patients with Psoriasis.
Aizawa N; Ishiuji Y; Tominaga M; Sakata S; Takahashi N; Yanaba K; Umezawa Y; Asahina A; Kimura U; Suga Y; Takamori K; Nakagawa H
J Immunol Res; 2019; 2019():8171373. PubMed ID: 30805373
[TBL] [Abstract][Full Text] [Related]
26. Serum macrophage-derived chemokine (MDC) levels are closely related with the disease activity of atopic dermatitis.
Kakinuma T; Nakamura K; Wakugawa M; Mitsui H; Tada Y; Saeki H; Torii H; Komine M; Asahina A; Tamaki K
Clin Exp Immunol; 2002 Feb; 127(2):270-3. PubMed ID: 11876749
[TBL] [Abstract][Full Text] [Related]
27. Expression pattern of somatostatin receptor subtypes 1-5 in human skin: an immunohistochemical study of healthy subjects and patients with psoriasis or atopic dermatitis.
Hagströmer L; Emtestam L; Stridsberg M; Talme T
Exp Dermatol; 2006 Dec; 15(12):950-7. PubMed ID: 17083361
[TBL] [Abstract][Full Text] [Related]
28. Skin levels of arachidonic acid-derived inflammatory mediators and histamine in atopic dermatitis and psoriasis.
Ruzicka T; Simmet T; Peskar BA; Ring J
J Invest Dermatol; 1986 Feb; 86(2):105-8. PubMed ID: 3018086
[TBL] [Abstract][Full Text] [Related]
29. Elevated serum levels of APRIL, but not BAFF, in patients with atopic dermatitis.
Matsushita T; Fujimoto M; Echigo T; Matsushita Y; Shimada Y; Hasegawa M; Takehara K; Sato S
Exp Dermatol; 2008 Mar; 17(3):197-202. PubMed ID: 17979975
[TBL] [Abstract][Full Text] [Related]
30. Increased carbonyl protein level in the stratum corneum of inflammatory skin disorders: A non-invasive approach.
Iwai I; Shimadzu K; Kobayashi Y; Hirao T; Etou T
J Dermatol; 2010 Aug; 37(8):693-8. PubMed ID: 20649709
[TBL] [Abstract][Full Text] [Related]
31. Study of serum levels and skin expression of S100B protein in psoriasis.
Salem SAM; El-Khateeb EA; Harvy M; Emam HME; Abdelaal W; Nemr RE; El-Hagry OO
An Bras Dermatol; 2017; 92(3):323-328. PubMed ID: 29186242
[TBL] [Abstract][Full Text] [Related]
32. Multiple tissue kallikrein mRNA and protein expression in normal skin and skin diseases.
Komatsu N; Saijoh K; Toyama T; Ohka R; Otsuki N; Hussack G; Takehara K; Diamandis EP
Br J Dermatol; 2005 Aug; 153(2):274-81. PubMed ID: 16086736
[TBL] [Abstract][Full Text] [Related]
33. Upregulation of High Mobility Group Box 1 May Contribute to the Pathogenesis of Biliary Atresia.
Ye CJ; Wang J; Yang YF; Shen Z; Chen G; Huang YL; Zheng YJ; Dong R; Zheng S
Eur J Pediatr Surg; 2019 Aug; 29(4):388-393. PubMed ID: 29909604
[TBL] [Abstract][Full Text] [Related]
34. Antibodies against High Mobility Group Box protein-1 (HMGB1) versus other anti-nuclear antibody fine-specificities and disease activity in systemic lupus erythematosus.
Wirestam L; Schierbeck H; Skogh T; Gunnarsson I; Ottosson L; Erlandsson-Harris H; Wetterö J; Sjöwall C
Arthritis Res Ther; 2015 Nov; 17():338. PubMed ID: 26596890
[TBL] [Abstract][Full Text] [Related]
35. Enhancement of mRNA expression of survivin and human beta-defensin-3 in lesions of psoriasis vulgaris.
Wang F; Zhang X; Xia P; Zhang L; Zhang Z
Eur J Dermatol; 2016; 26(1):28-33. PubMed ID: 26771657
[TBL] [Abstract][Full Text] [Related]
36. Alarmins HMGB1, IL-33, S100A7, and S100A12 in Psoriasis Vulgaris.
Borsky P; Fiala Z; Andrys C; Beranek M; Hamakova K; Malkova A; Svadlakova T; Krejsek J; Palicka V; Borska L; Rehacek V
Mediators Inflamm; 2020; 2020():8465083. PubMed ID: 32377165
[TBL] [Abstract][Full Text] [Related]
37. Elevated platelet activation in patients with atopic dermatitis and psoriasis: increased plasma levels of beta-thromboglobulin and platelet factor 4.
Tamagawa-Mineoka R; Katoh N; Ueda E; Masuda K; Kishimoto S
Allergol Int; 2008 Dec; 57(4):391-6. PubMed ID: 18797178
[TBL] [Abstract][Full Text] [Related]
38. Involvement of high mobility group box-1 in imiquimod-induced psoriasis-like mice model.
Chen T; Fu LX; Guo ZP; Yin B; Cao N; Qin S
J Dermatol; 2017 May; 44(5):573-581. PubMed ID: 27943400
[TBL] [Abstract][Full Text] [Related]
39. Role of the tumor necrosis factor family member LIGHT in the pathogenesis of atopic dermatitis.
Seifeldin NS; El Sayed SB; Asaad MK; Aly AA
Int J Dermatol; 2015 Oct; 54(10):e376-82. PubMed ID: 26043794
[TBL] [Abstract][Full Text] [Related]
40. The atopic dermatitis blood signature is characterized by increases in inflammatory and cardiovascular risk proteins.
Brunner PM; Suárez-Fariñas M; He H; Malik K; Wen HC; Gonzalez J; Chan TC; Estrada Y; Zheng X; Khattri S; Dattola A; Krueger JG; Guttman-Yassky E
Sci Rep; 2017 Aug; 7(1):8707. PubMed ID: 28821884
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
